Bioverse, Inc. dba Bioverse
Drug manufacturer
Bioverse, Inc. dba Bioverse has 1 FDA warning letter on file.
FDA record
Recent FDA actions
Questions about Bioverse, Inc. dba Bioverse
Yes. FDA has published 1 warning letter naming Bioverse, Inc. dba Bioverse; the latest was posted on 2025-09-16. Each letter links to FDA's own posting.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Bioverse, Inc. dba Bioverse; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.
Approve Suite is not affiliated with Bioverse, Inc. dba Bioverse.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.